Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Large Insider Purchases

Institutional-Scale SEC Form 4 Buy Signals

The Signal of $1M+ Conviction

When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.

Filing Date Trade Date Ticker Company Name Reporting Person Relationship Industry Type Price Qty Total, $ Owned After Change, %
2021-09-24 23:34 2021-09-22 SXT SENSIENT TECHNOLOGIES CORP Winder Investment Pte Ltd 10% owner Industrial Organic Chemicals BUY $91.83 32,602 $2,993,871 4,853,997 +0.7%
2021-09-24 23:05 2021-09-24 N/A N/A Packer Craig Director, Officer - CEO and President Other BUY $15.11 628,541 $9,497,255 2,879,122 +27.9%
2021-09-25 02:57 2021-09-22 NRDY Nerdy Inc. LIGHT STREET CAPITAL MANAGEMENT, LLC 10% owner Services-Educational Services BUY $12.38 100,000 $1,238,110 135,893 +278.6%
2021-09-24 23:05 2021-09-24 N/A N/A Kirshenbaum Alan Officer - Executive Vice President Other BUY $15.11 628,541 $9,497,255 2,879,122 +27.9%
2021-09-25 00:00 2021-09-22 MYOV Myovant Sciences Ltd. Sumitomo Chemical Co., Ltd. 10% owner Pharmaceutical Preparations BUY $22.39 138,796 $3,108,225 49,936,504 +0.3%
2021-09-25 00:02 2021-09-22 CQP Cheniere Energy Partners, L.P. BX Rockies Platform Co LLC 10% owner Natural Gas Distribution BUY $39.60 30,467 $1,206,618 67 +100.0%
2021-09-24 18:58 2021-09-22 RDUS N/A BIOTECH TARGET N V 10% owner Other BUY $12.28 150,000 $1,841,280 7,605,714 +2.0%
2021-09-25 00:02 2021-09-22 CQP Cheniere Energy Partners, L.P. Blackstone Holdings III L.P. 10% owner Natural Gas Distribution BUY $39.60 30,400 $1,203,937 30,400 +100.0%
2021-09-25 00:28 2021-09-22 N-A Copper Property CTL Pass Through Trust Silver Point Capital L.P. 10% owner Real Estate BUY $20.00 141,000 $2,820,000 13,923,439 +1.0%
2021-09-23 16:43 2021-09-21 N/A Copper Property CTL Pass Through Trust BYWAY 1 CORP. 10% owner Real Estate BUY $19.13 7,062,727 $135,074,654 18,946,567 +59.4%
2021-09-24 01:00 2021-09-23 HHGC N/A HOOY Kok Wai 10% owner Other BUY $10.00 255,000 $2,550,000 1,437,500 +21.6%
2021-09-23 22:46 2021-09-10 N/A N/A Saudi National Bank 10% owner Other BUY $20.79 417,625 $8,682,424 2,606,087 +19.1%
2021-09-23 23:32 2021-09-21 SXT SENSIENT TECHNOLOGIES CORP Winder Investment Pte Ltd 10% owner Industrial Organic Chemicals BUY $89.92 26,965 $2,424,741 4,821,395 +0.6%
2021-09-23 16:30 2021-09-21 VRDN Viridian Therapeutics, Inc.\DE Fairmount Funds Management LLC Director, 10% owner Pharmaceutical Preparations BUY $11.00 909,000 $9,999,000 938,233 +3,109.5%
2021-09-23 18:50 2021-09-21 MTEM N/A BIOTECH TARGET N V 10% owner Other BUY $6.00 750,000 $4,500,000 10,792,003 +7.5%
2021-09-23 00:07 2021-09-20 SXT SENSIENT TECHNOLOGIES CORP Winder Investment Pte Ltd 10% owner Industrial Organic Chemicals BUY $89.63 36,105 $3,236,073 4,794,430 +0.8%
2021-09-23 00:00 2021-09-20 MYOV Myovant Sciences Ltd. Sumitomo Chemical Co., Ltd. 10% owner Pharmaceutical Preparations BUY $22.30 81,273 $1,812,120 49,797,708 +0.2%
2021-09-23 02:26 2021-09-20 CRCT Cricut, Inc. Abdiel Capital Management, LLC 10% owner Special Industry Machinery, NEC BUY $30.40 268,671 $8,167,545 9,363,825 +3.0%
2021-09-22 23:54 2021-09-20 GMS N/A Coliseum Capital Management, LLC 10% owner Other BUY $43.12 89,247 $3,848,331 5,292,003 +1.7%
2021-09-23 03:19 2021-09-20 LIFE aTYR PHARMA INC SCHIMMEL PAUL Director Biological Products, (No Diagnostic Substances) BUY $8.00 250,000 $2,000,000 252,890 +8,650.5%
2021-09-21 23:43 2021-09-17 SXT SENSIENT TECHNOLOGIES CORP Winder Investment Pte Ltd 10% owner Industrial Organic Chemicals BUY $91.62 60,000 $5,497,254 4,758,325 +1.3%
2021-09-22 01:39 2021-09-17 ALPN N/A Decheng Capital China Life Sciences USD Fund III, L.P. 10% owner Other BUY $9.40 1,542,553 $14,499,998 4,708,288 +48.7%
2021-09-22 01:36 2021-09-17 PRCT PROCEPT BioRobotics Corp Desai Antal Rohit Director, 10% owner Surgical & Medical Instruments & Apparatus BUY $25.00 440,000 $11,000,000 11,222,662 +4.1%
2021-09-21 23:03 2021-09-17 TYRA Tyra Biosciences, Inc. Cormorant Asset Management, LP Other Pharmaceutical Preparations BUY $16.00 312,500 $5,000,000 1,069,932 +41.3%
2021-09-22 04:55 2021-09-17 PACE Nerdy Inc. LIGHT STREET CAPITAL MANAGEMENT, LLC 10% owner Services-Educational Services BUY $10.01 2,827,502 $28,307,819 120,893 +100.0%
2021-09-22 00:12 2021-09-17 ALPN N/A Cui Xiangmin Director, 10% owner Other BUY $9.40 1,542,553 $14,499,998 4,708,288 +48.7%
2021-09-22 01:34 2021-09-17 PRCT PROCEPT BioRobotics Corp CPMG Inc 10% owner Surgical & Medical Instruments & Apparatus BUY $25.00 440,000 $11,000,000 11,222,662 +4.1%
2021-09-22 01:38 2021-09-17 ALPN N/A Thompson Peter A. Director, 10% owner Other BUY $9.40 1,010,637 $9,499,988 425,531 +100.0%
2021-09-21 22:54 2021-09-17 N/A N/A Golub Lawrence E Director, Officer, 10% owner - CHAIRMAN Other BUY $15.00 408,042 $6,120,630 1,224,742 +50.0%
2021-09-21 22:48 2021-09-17 N/A N/A Golub David Director, Officer, 10% owner - President and CEO Other BUY $15.00 408,042 $6,120,630 1,224,742 +50.0%
2021-09-22 01:34 2021-09-17 PRCT PROCEPT BioRobotics Corp MOLL FREDERIC H Director Surgical & Medical Instruments & Apparatus BUY $25.00 400,000 $10,000,000 882,521 +82.9%
2021-09-21 23:27 2021-09-17 PRCT PROCEPT BioRobotics Corp VIKING GLOBAL INVESTORS LP 10% owner Surgical & Medical Instruments & Apparatus BUY $35.00 400,000 $14,000,000 400,000 +100.0%
2021-09-22 01:42 2021-09-17 ALPN N/A ORBIMED ADVISORS LLC Director, 10% owner Other BUY $9.40 1,010,637 $9,499,988 425,531 +100.0%
2021-09-22 03:58 2021-09-17 RBOT Vicarious Surgical Inc. Khosla Ventures V, L.P. 10% owner Orthopedic, Prosthetic & Surgical Appliances & Supplies BUY $10.00 333,334 $3,333,340 13,059,335 +2.6%
2021-09-21 00:09 2021-09-16 SXT SENSIENT TECHNOLOGIES CORP Winder Investment Pte Ltd 10% owner Industrial Organic Chemicals BUY $93.09 28,163 $2,621,694 4,698,325 +0.6%
2021-09-21 04:19 2021-09-17 DICE N/A Northpond Ventures GP, LLC 10% owner Other BUY $17.00 235,000 $3,995,000 3,292,871 +7.7%
2021-09-21 00:00 2021-09-16 MYOV Myovant Sciences Ltd. Sumitomo Chemical Co., Ltd. 10% owner Pharmaceutical Preparations BUY $22.20 87,913 $1,951,660 49,716,435 +0.2%
2021-09-20 23:30 2021-09-17 DICE N/A RA CAPITAL MANAGEMENT, L.P. Director, 10% owner Other BUY $17.00 1,400,000 $23,800,000 786,407 +100.0%
2021-09-20 19:21 2021-09-16 MGNX MACROGENICS INC BIOTECH TARGET N V 10% owner Pharmaceutical Preparations BUY $20.61 600,000 $12,363,480 6,875,564 +9.6%
2021-09-21 02:20 2021-09-16 DBI Designer Brands Inc. SCHOTTENSTEIN JAY L Director, Officer, 10% owner - Executive Chairman Retail-Shoe Stores BUY $12.82 1,488,933 $19,082,612 1,667,527 +833.7%
2021-09-21 00:17 2021-09-16 GPOR GULFPORT ENERGY CORP Silver Point Capital L.P. Director, 10% owner Crude Petroleum & Natural Gas BUY $79.51 81,251 $6,460,543 9,090,918 +0.9%
2021-09-18 03:51 2021-09-17 ATER Aterian, Inc. 9830 Macarthur, LLC 10% owner Electric Housewares & Fans BUY $7.71 1,468,700 $11,323,677 3,246,701 +82.6%
2021-09-18 00:16 2021-09-15 SXT SENSIENT TECHNOLOGIES CORP Winder Investment Pte Ltd 10% owner Industrial Organic Chemicals BUY $93.01 35,824 $3,332,001 4,670,162 +0.8%
2021-09-18 00:05 2021-09-16 OSCR Oscar Health, Inc. Schlosser Mario Director, Officer - Chief Executive Officer Hospital & Medical Service Plans BUY $17.53 57,300 $1,004,515 57,317 +337,058.8%
2021-09-17 21:25 2021-09-15 AVTX Avalo Therapeutics, Inc. ARMISTICE CAPITAL, LLC Director, 10% owner Pharmaceutical Preparations BUY $2.20 5,700,000 $12,557,670 45,000,000 +14.5%
2021-09-18 01:26 2021-09-15 CRCT Cricut, Inc. Abdiel Capital Management, LLC 10% owner Special Industry Machinery, NEC BUY $30.98 531,926 $16,478,695 9,095,144 +6.2%
2021-09-17 23:16 2021-09-15 CLR N/A Hamm Harold Director, 10% owner Other BUY $41.99 261,709 $10,988,114 13,691,717 +1.9%
2021-09-17 23:34 2021-09-17 TYRA Tyra Biosciences, Inc. RA CAPITAL MANAGEMENT, L.P. Director, 10% owner Pharmaceutical Preparations BUY $16.00 1,250,000 $20,000,000 5,297,120 +30.9%
2021-09-17 23:48 2021-09-17 TYRA Tyra Biosciences, Inc. MORE ROBERT J Director Pharmaceutical Preparations BUY $16.00 156,250 $2,500,000 4,080,296 +4.0%
2021-09-17 23:47 2021-09-17 TYRA Tyra Biosciences, Inc. Alta Partners NextGen Fund II Management, LLC 10% owner Pharmaceutical Preparations BUY $16.00 156,250 $2,500,000 4,080,296 +4.0%
SHOW ENTRIES

Institutional Conviction in Form 4

Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.

Filtering the Market Noise

Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.